跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAR-T HER2
首页
药物
CAR-T HER2
CAR-T HER2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CAR-T cell targeting HER2 and expressing endogenous RNA and application of CAR-T cell
申请人: SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN
优先权: 2022
CN
AN ANTI-HER2 SCFV-SECRETING ARMOURED CAR T CELL
申请人: LEIBNIZ INST FUER IMMUNTHERAPIE LIT
优先权: 2025
WO
Universal HER2 CAR-T cell for expressing HLA-G as well as preparation method and application of universal HER2 CAR-T cell
申请人: HENAN UNIV OF MEDICINE
优先权: 2026
CN
CAR-T expression vector targeting HER2 as well as construction and application of CAR-T expression vector
申请人: INST BASIC MEDICAL SCIENCES CAMS
优先权: 2020
CN
HER2-targeting universal CAR-T cell and preparation method thereof
申请人: NINGBO MAOXING BIOMEDICAL TECH CO LTD
优先权: 2021
CN
Her2-CAR-T system construction method based on PiggyBac vector
申请人: MA XIAODONG
优先权: 2018
CN
CAR-T cell targeting ALPPL2 and HER2 proteins and application thereof
申请人: UNIV SUN YAT SEN
优先权: 2025
CN
Preparation and application of double targeting point CAR T targeting FOLR1 and HER2
申请人: FOSUNKITE BIOTECHNOLOGY CO LTD
优先权: 2021
CN
药物
反馈